See Today's Golden Star Stocks 🔥 Free for 7 Days See Today's Golden Star Stocks 🔥 Free for 7 Days

News Digest / Income Statements

Income Statements

08:11am, Tuesday, Aug 12, 2025

Adverum Launches Ixo‑vec Phase 3 Amid Cash Crunch, Heavy Lease Liabilities

Snapshot - Adverum Biotechnologies, Inc. (NASDAQ: ADVM) What's happening inside the company - Advancing lead gene‑therapy candidate ixoberogene soroparvovec (Ixo‑vec): ARTEMIS Phase 3 initiated Feb 2025; enrollment expected complete Q1 2026; top‑line ARTEMIS data expected H1 2027. - LUNA Phase 2 ...

08:09am, Tuesday, Aug 12, 2025

Korro Bio advances KRRO‑110, secures Novo Nordisk deal; runway into 2027 despite rising burn

08:09am, Tuesday, Aug 12, 2025

Centessa pivots to OX2R franchise, $15M Genmab deal and $404M liquidity

08:08am, Tuesday, Aug 12, 2025

Climb Bio advances B-cell pipeline, $187M liquidity and runway to 2027 amid risks

08:07am, Tuesday, Aug 12, 2025

Passage Bio pivots, cuts costs and extends runway; PBFT02 boosts PGRN but safety, funding risks

08:05am, Tuesday, Aug 12, 2025

Zenas BioPharma funded into 2026 but burning cash; obexelimab trials pose binary risk

Z

08:04am, Tuesday, Aug 12, 2025

TScan ramps R&D and recognizes Amgen revenue, but heavy cash burn tests runway to Q1 2027

T

08:03am, Tuesday, Aug 12, 2025

Sable Offshore restarts production; must refinance Jan 2026 amid legal, regulatory risk

S

08:02am, Tuesday, Aug 12, 2025

Grace Therapeutics files NDA for GTx‑104 after Phase 3 win, $20M cash and $13.7M raise

08:01am, Tuesday, Aug 12, 2025

Mereo advances Phase 3 setrusumab; debt conversion cuts interest but cash burn continues

07:03am, Tuesday, Aug 12, 2025

DarioHealth trims costs, boosts gross margin but cites going-concern, faces covenant breach

D

07:02am, Tuesday, Aug 12, 2025

Liquidia launches FDA-approved YUTREPIA, posts initial sales amid heavy losses and legal risk

07:01am, Tuesday, Aug 12, 2025

NeurAxis Q2: Revenues +46% but operating losses, going-concern and dilution risks remain

N

07:01am, Tuesday, Aug 12, 2025

Milestone Pharma eyes Dec 13, 2025 PDUFA; $48.7M offering boosts runway amid debt, no revenue

06:21pm, Monday, Aug 11, 2025

MRCC Q2: NAV slips, portfolio markdowns and non-accruals; strong cash flow, merger set

06:19pm, Monday, Aug 11, 2025

Synchronoss Q2: Operating gains from cost cuts but $19.6M GAAP loss amid FX, debt costs

06:19pm, Monday, Aug 11, 2025

Humacyte launches Symvess after FDA approval; early sales, heavy burn and volatile earnings

06:18pm, Monday, Aug 11, 2025

GSR III Holds $236M Trust but Faces Tight Cash, Going-Concern; Terra Deal Pivotal

06:17pm, Monday, Aug 11, 2025

SmartFinancial Q2: Loan, deposit growth drives higher NII/NIM and profits; provisions, expenses rise

06:16pm, Monday, Aug 11, 2025

GrowGeneration Q2: Sales Fall 24%, Restructuring Cuts Costs, Margins Improve, ERP Fix Underway

06:15pm, Monday, Aug 11, 2025

Maravai posts steep revenue, margin decline, $42.9M goodwill hit; plans 25% workforce cut

06:14pm, Monday, Aug 11, 2025

Plug Power shrinks costs, secures DOE loan and high-cost debt as losses remain deep

06:13pm, Monday, Aug 11, 2025

Nauticus Robotics' SeaTrepid Acquisition Drives Revenue Growth Amid Heavy Debt and Losses

K

06:13pm, Monday, Aug 11, 2025

Quipt: Cash-generative core and positive EBITDA, but revenue slips and DOJ probe looms

06:12pm, Monday, Aug 11, 2025

Gyre pivots to China commercial pharma; launches Etorel and Contiva, raises cash, revenue dips

06:11pm, Monday, Aug 11, 2025

NET Power Q2: $360M Goodwill Impairment, Project Permian Paused; Liquidity Holds

N

06:10pm, Monday, Aug 11, 2025

TPB Q2: Stoker's Boosts Sales 25%; Debt Refinance Raises Interest Costs, SG&A Up

T

06:09pm, Monday, Aug 11, 2025

WOW Q2: Revenue Falls, Loss Widens on Rising Interest; $5.20 Take-Private Deal

06:08pm, Monday, Aug 11, 2025

Spirit Airlines Emerges from Chapter 11 but Posts Big Q2 Losses, Faces Liquidity Risk

06:07pm, Monday, Aug 11, 2025

Horizon Space SPAC reports GAAP profit from $22.5M trust but $3M working capital deficit

06:06pm, Monday, Aug 11, 2025

Microvast shows operational gains and cash flow but $121M fair-value hit raises liquidity risk

06:05pm, Monday, Aug 11, 2025

Primis posts profit on PFH deconsolidation gain; credit losses, costs persist

F

06:04pm, Monday, Aug 11, 2025

Hallador Energy returns to profit, Merom-focused shift and $35M prepaid deal boost cash

06:03pm, Monday, Aug 11, 2025

Capricor posts widening losses, $122.8M cash runway as FDA CRL and HOPE-3 topline loom

06:02pm, Monday, Aug 11, 2025

Bally's completes Queen merger, increases Intralot stake but posts huge GAAP loss

06:02pm, Monday, Aug 11, 2025

Richtech shifts to RaaS, raises $71M via ATM but G&A spike widens losses despite $85M liquidity

R

06:01pm, Monday, Aug 11, 2025

Dominari pivots to financial services; Q2 revenue soars, net income on unrealized gains

05:31pm, Monday, Aug 11, 2025

Hillenbrand posts tiny Q3 profit; revenue, adjusted EBITDA fall as TerraSource sale boosts liquidity

05:30pm, Monday, Aug 11, 2025

Xenon ramps Phase‑3 push with $625M runway; X‑TOLE2 topline due early 2026

05:29pm, Monday, Aug 11, 2025

Ouster Q2: Revenue +30%, gross margin 45%, $229M cash runway; losses narrow amid litigation

«
1
2
...
20
21
22
23
24
25
26
...
111
112
»